Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug.

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...

Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855) ('Ascentage” or the 'Company”), a global ...

The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively ...

When blockbuster drugs lose intellectual property protections it can wipe out billions of dollars in revenue for companies ...

Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855) ('Ascentage” or the 'Company”), a global ...

As a consequence of Pfizer’s innovation, the price of citric acid tumbled over the succeeding decades, with the value of the chemical falling by 5/6ths in 20 years.

As scientific breakthroughs continue to transform medicine in 2025, companies across the biotech and pharmaceutical sectors ...

The Dow Jones Industrial Average climbed on Thursday (July 10) as investors brushed aside concerns over new tariff ...

Welcome to our live blog tracking the latest news and developments from the United States. Stay updated with real-time ...

The goal is to make drug prices more in line with European ones. If this were the case, it could result in a massive 24% hit on all firms’ US drug revenue, detrimental to Pfizer.